Acquired von Willebrand syndrome in patients treated with veno-arterial extracorporeal membrane oxygenation

Toshihiro Tamura(Tenri Hospital), Yoshihisa Nakagawa(Shiga University of Medical Science), Hirokazu Kondo(Tenri Hospital), Maiko Kuroda(Tenri Hospital), Masayuki Fuki(Tenri Hospital), Makoto Miyake(Tenri Hospital), Soichiro Enomoto(The University of Tokyo), Yuki Obayashi(Kyoto University), Hisanori Horiuchi(Unknown), Miyako Imanaka(Tenri Hospital), Chisato Izumi(National Cerebral and Cardiovascular Center), Shunsuke Nishimura(Norwegian Womens Public Health Association), Masashi Amano(National Cerebral and Cardiovascular Center), Jiro Sakamoto(Tenri Hospital), Yodo Tamaki(Tenri Hospital)
Cardiovascular Intervention and Therapeutics
January 17, 2019
10.1007/s12928-019-00568-y
Cited by 37

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582
Three-Year Follow-up after Implantation of Metallic Coronary-Artery Stents
|New England Journal of Medicine|1996|507
JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
|Circulation Journal|2020|363
Effect of Intensive Statin Therapy on Regression of Coronary Atherosclerosis in Patients With Acute Coronary Syndrome
|Journal of the American College of Cardiology|2009|359